Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-25-017403
Filing Date
2025-01-30
Accepted
2025-01-30 18:40:41
Documents
5
Effectiveness Date
2025-01-30

Document Format Files

Seq Description Document Type Size
1 S-1MEF d919429ds1mef.htm S-1MEF 32313
2 EX-5.1 d919429dex51.htm EX-5.1 11091
3 EX-23.1 d919429dex231.htm EX-23.1 1824
4 EX-FILING FEES d919429dexfilingfees.htm EX-FILING FEES 15480
5 GRAPHIC g919429g93p37.jpg GRAPHIC 9347
  Complete submission text file 0001193125-25-017403.txt   69440
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-284612 | Film No.: 25575239
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)